266 related articles for article (PubMed ID: 37072351)
1. Irreversible electroporation augments β-glucan induced trained innate immunity for the treatment of pancreatic ductal adenocarcinoma.
Woeste MR; Shrestha R; Geller AE; Li S; Montoya-Durango D; Ding C; Hu X; Li H; Puckett A; Mitchell RA; Hayat T; Tan M; Li Y; McMasters KM; Martin RCG; Yan J
J Immunother Cancer; 2023 Apr; 11(4):. PubMed ID: 37072351
[TBL] [Abstract][Full Text] [Related]
2. Treatment of pancreatic cancer with irreversible electroporation and intratumoral CD40 antibody stimulates systemic immune responses that inhibit liver metastasis in an orthotopic model.
Shankara Narayanan JS; Hayashi T; Erdem S; McArdle S; Tiriac H; Ray P; Pu M; Mikulski Z; Miller A; Messer K; Carson D; Schoenberger S; White RR
J Immunother Cancer; 2023 Jan; 11(1):. PubMed ID: 36634919
[TBL] [Abstract][Full Text] [Related]
3. Irreversible Electroporation Combined with Checkpoint Blockade and TLR7 Stimulation Induces Antitumor Immunity in a Murine Pancreatic Cancer Model.
Narayanan JSS; Ray P; Hayashi T; Whisenant TC; Vicente D; Carson DA; Miller AM; Schoenberger SP; White RR
Cancer Immunol Res; 2019 Oct; 7(10):1714-1726. PubMed ID: 31409607
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous Delivery of Dual Inhibitors of DNA Damage Repair Sensitizes Pancreatic Cancer Response to Irreversible Electroporation.
Long X; Dai A; Huang T; Niu W; Liu L; Xu H; Yin T; Jiang T; Sun S; Lei P; Li C; Zhu X; Zhao J
ACS Nano; 2023 Jul; 17(13):12915-12932. PubMed ID: 37352467
[TBL] [Abstract][Full Text] [Related]
5. A Syngeneic Pancreatic Cancer Mouse Model to Study the Effects of Irreversible Electroporation.
Shankara Narayanan JS; Ray P; Naqvi I; White R
J Vis Exp; 2018 Jun; (136):. PubMed ID: 29939178
[TBL] [Abstract][Full Text] [Related]
6. The induction of peripheral trained immunity in the pancreas incites anti-tumor activity to control pancreatic cancer progression.
Geller AE; Shrestha R; Woeste MR; Guo H; Hu X; Ding C; Andreeva K; Chariker JH; Zhou M; Tieri D; Watson CT; Mitchell RA; Zhang HG; Li Y; Martin Ii RCG; Rouchka EC; Yan J
Nat Commun; 2022 Feb; 13(1):759. PubMed ID: 35140221
[TBL] [Abstract][Full Text] [Related]
7. Irreversible electroporation as treatment of locally advanced and as margin accentuation in borderline resectable pancreatic adenocarcinoma.
Marsanic P; Mellano A; Sottile A; De Simone M
Med Biol Eng Comput; 2017 Jul; 55(7):1123-1127. PubMed ID: 28078482
[TBL] [Abstract][Full Text] [Related]
8. Orally administered particulate beta-glucan modulates tumor-capturing dendritic cells and improves antitumor T-cell responses in cancer.
Li B; Cai Y; Qi C; Hansen R; Ding C; Mitchell TC; Yan J
Clin Cancer Res; 2010 Nov; 16(21):5153-64. PubMed ID: 20855461
[TBL] [Abstract][Full Text] [Related]
9. Irreversible electroporation therapy in the management of locally advanced pancreatic adenocarcinoma.
Martin RC; McFarland K; Ellis S; Velanovich V
J Am Coll Surg; 2012 Sep; 215(3):361-9. PubMed ID: 22726894
[TBL] [Abstract][Full Text] [Related]
10. Irreversible Electroporation for Locally Advanced Pancreatic Cancer.
Timmer FEF; Geboers B; Ruarus AH; Schouten EAC; Nieuwenhuizen S; Puijk RS; de Vries JJJ; Meijerink MR; Scheffer HJ
Tech Vasc Interv Radiol; 2020 Jun; 23(2):100675. PubMed ID: 32591191
[TBL] [Abstract][Full Text] [Related]
11. Irreversible electroporation ablation overcomes tumor-associated immunosuppression to improve the efficacy of DC vaccination in a mice model of pancreatic cancer.
Yang J; Eresen A; Shangguan J; Ma Q; Yaghmai V; Zhang Z
Oncoimmunology; 2021 Feb; 10(1):1875638. PubMed ID: 33643692
[TBL] [Abstract][Full Text] [Related]
12. Irreversible electroporation promotes a pro-inflammatory tumor microenvironment and anti-tumor immunity in a mouse pancreatic cancer model.
Imran KM; Brock RM; Beitel-White N; Powar M; Orr K; Aycock KN; Alinezhadbalalami N; Salameh ZS; Eversole P; Tintera B; Markov Madanick J; Hendricks-Wenger A; Coutermarsh-Ott S; Davalos RV; Allen IC
Front Immunol; 2024; 15():1352821. PubMed ID: 38711517
[TBL] [Abstract][Full Text] [Related]
13. Irreversible electroporation combined with chemotherapy and PD-1/PD-L1 blockade enhanced antitumor immunity for locally advanced pancreatic cancer.
Ma Y; Xing Y; Li H; Yuan T; Liang B; Li R; Li J; Li Z; Li S; Niu L
Front Immunol; 2023; 14():1193040. PubMed ID: 37691923
[TBL] [Abstract][Full Text] [Related]
14. Treatment of locally advanced pancreatic cancer by percutaneous and intraoperative irreversible electroporation: general hospital cancer center experience.
Lambert L; Horejs J; Krska Z; Hoskovec D; Petruzelka L; Krechler T; Kriz P; Briza J
Neoplasma; 2016; 63(2):269-73. PubMed ID: 26774149
[TBL] [Abstract][Full Text] [Related]
15. Open irreversible electroporation for isolated local recurrence of pancreatic ductal adenocarcinoma after primary surgery.
Heger U; Mack C; Tjaden C; Pan F; Pausch T; Hinz U; Sommer CM; Hackert T
Pancreatology; 2021 Oct; 21(7):1349-1355. PubMed ID: 34404600
[TBL] [Abstract][Full Text] [Related]
16. Immunometabolic changes of β-glucan-trained immunity induction and inhibition on neonatal calf immune innate cells.
Angulo M; Angulo C
Mol Immunol; 2023 Jul; 159():58-68. PubMed ID: 37271010
[TBL] [Abstract][Full Text] [Related]
17. Differential pathways regulating innate and adaptive antitumor immune responses by particulate and soluble yeast-derived β-glucans.
Qi C; Cai Y; Gunn L; Ding C; Li B; Kloecker G; Qian K; Vasilakos J; Saijo S; Iwakura Y; Yannelli JR; Yan J
Blood; 2011 Jun; 117(25):6825-36. PubMed ID: 21531981
[TBL] [Abstract][Full Text] [Related]
18. Exploration of Novel Pathways Underlying Irreversible Electroporation Induced Anti-Tumor Immunity in Pancreatic Cancer.
Imran KM; Nagai-Singer MA; Brock RM; Alinezhadbalalami N; Davalos RV; Allen IC
Front Oncol; 2022; 12():853779. PubMed ID: 35372046
[TBL] [Abstract][Full Text] [Related]
19. Treatment of locally advanced pancreatic cancer with irreversible electroporation - a Danish single center study of safety and feasibility.
Flak RV; Stender MT; Jensen TM; Andersen KL; Henriksen SD; Mortensen PB; Sall M; Thorlacius-Ussing O
Scand J Gastroenterol; 2019 Feb; 54(2):252-258. PubMed ID: 30907286
[TBL] [Abstract][Full Text] [Related]
20. Irreversible Electroporation: An Emerging Immunomodulatory Therapy on Solid Tumors.
Zhang N; Li Z; Han X; Zhu Z; Li Z; Zhao Y; Liu Z; Lv Y
Front Immunol; 2021; 12():811726. PubMed ID: 35069599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
